Systemically delivered small molecule STING agonists as next generation cancer immunotherapies

Therapeutic Innovation Australia 2026 Open access

Read full text
Authors: Therapeutic Innovation Australia
DOI: 10.82292/cgp4-vr86
Cited by: 0

Fields of Study & Subjects

interferon and immune responses Cancer Immunotherapy and Biomarkers Immunotherapy and Immune Responses

Publication details

Journal / source
Therapeutic Innovation Australia
Publication date
17 February 2026
Language
EN